Kidswant Children Products Co (301078) Fair Value & Analysis
Consumer Cyclical · CN · Market cap 10.0B CNY
Analysis
Kidswant Children Products Co (301078) currently trades at ¥7.47, while our model-based Fair Value estimate is ¥5.18 — implying the stock looks roughly 30.7% overvalued today. We read business quality at 92/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Kidswant Children Products Co.,Ltd., together with its subsidiaries, engages in the retail and value-added services of maternal and infant products in China. It operates through Maternal and Infant Products and Services; and Scalp and Hair Care Business segments. The company sells food comprising milk powder and baby food; consumables consisting of diapers and toiletries; durable goods, including toys, strollers, and cribs; clothing and maternity products; and scalp and hair care products under the Silk Domain brand. It also provides children's playgrounds, interactive activities, and other services for pregnant women and infants; maternal and infant services, including childcare and Black Gold membership services; professional care services for scalp and hair care, including examination and assessment, personalized care design, instrument application, relaxation experiences, and result follow-up guidance; supplier services comprising membership development, naming of interactive ac…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.